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Abstract
Background: Response to painful stimuli is susceptible to genetic variation. Numerous loci have been identified which
contribute to this variation, one of which, MC1R, is better known as a gene involved in mammalian hair colour. MC1R is a G
protein-coupled receptor expressed in melanocytes and elsewhere and mice lacking MC1R have yellow hair, whilst humans
with variant MC1R protein have red hair. Previous work has found differences in acute pain perception, and response to
analgesia in mice and humans with mutations or variants in MC1R.
Methodology and Principal Findings: We have tested responses to noxious and non-noxious stimuli in mutant mice which
lack MC1R, or which overexpress an endogenous antagonist of the receptor, as well as controls. We have also examined the
response of these mice to inflammatory pain, assessing the hyperalgesia and allodynia associated with persistent
inflammation, and their response to neuropathic pain. Finally we tested by a paired preference paradigm their aversion to
oral administration of capsaicin, which activates the noxious heat receptor TRPV1. Female mice lacking MC1R showed
increased tolerance to noxious heat and no alteration in their response to non-noxious mechanical stimuli. MC1R mutant
females, and females overexpressing the endogenous MC1R antagonist, agouti signalling protein, had a reduced formalin-
induced inflammatory pain response, and a delayed development of inflammation-induced hyperalgesia and allodynia. In
addition they had a decreased aversion to capsaicin at moderate concentrations. Male mutant mice showed no difference
from their respective controls. Mice of either sex did not show any effect of mutant genotype on neuropathic pain.
Conclusions: We demonstrate a sex-specific role for MC1R in acute noxious thermal responses and pain of inflammatory
origin.
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Introduction
Thesensationofpainservesasaprotective function,byalertingus
to real or impending injury, triggering protective responses [1]. In a
naı ¨ve animal, pain is initiated by direct thermal, mechanical or
chemicalactivationofspecificsubsetsoffineafferentC-and Ad-fibre
nociceptors. Individuals can differ in their perception of or response
to pain. Within the human population, there are several rare,
hereditary, sensory and autonomic neuropathies (HSANs) which are
characterized by failure in development of or by degeneration of
primary sensory and autonomic neurons [2]. Such conditions can
leadtoan impaired abilitytoperceivenoxiousstimuliand may result
in permanent damage as normally painful injuries go unnoticed.
There are also many non-pathological individual differences in
nociception. It is well established that the sexes differ in their
sensitivity to pain and in their responses to analgesia [3,4], with
females in general displaying greater sensitivity to pain than males
[5,6]. However this can be dependent upon genetic factors; for
example in the Sprague Dawley rat strain, males are more sensitive
than females to thermal nociception, while the opposite is seen in the
Long Evans rat strain [7]. Analysis of morphine-induced analgesia
further illustrates the complexity of sex in contributing to individual
differences. In several strains of mice (AKR/J, C57BL/6J, SWR/J)
males appear more sensitive to morphine, whilst in other strains
there are no sex differences and in one strain studied (CBA/J)
females are more sensitive than males [8].
Quantitative traitlocus (QTL)mappingallows forthe localisation
of genes responsible for strain variability in nociception. A number
of such loci have been reported among several different mouse
strains, including Nociq1 to 3 [9,10], Capsq1 to 4 [11], Tpnr1 to 3
[9,12,13] and Morph1 to 4 [14]. Two of the QTL reported, Morph1
and Morph4 co-localise with the strong candidate genes, Oprk and
Oprm, which encode kappa (k-) 1 and mu (m-) 1 opioid receptors
respectively[15]. A third opioid receptor gene, Orpd1, encoding the
delta (d-) opioid receptor, is alsoa strong candidate QTL, mediating
strain dependent (C57BL6/J and DBA2/J) differences for thermal
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Tpnr2, localises to, and affects the expression of calcitonin gene-
related peptide alpha (CGRPa), which has been shown to be
involved in noxious heat sensitivity [13].
Analysis of k-opioid-receptor agonist induced analgesia was
found to be NMDA-dependent in male but not female mice [16].
A QTL underlying the strain difference between C57BL/6J and
DBA2/J in kappa opioid analgesia was found on chromosome 8 in
female but not male mice [17]. Mogil et al suggested that Mc1r
may be a lead candidate gene underling this sex specific difference
in analgesia [17]. Melanocortin-1 receptor (MC1R) is a G protein-
coupled, seven transmembrane domain receptor that responds to
small peptide hormones, derived from pro-opiomelanocortin
(POMC) and belongs to a family of five receptors, MC1R to
MC5R. The function of MC1R is best understood in the
regulation of pigmentation through its expression in melanocytes.
Loss of function mutations in mice and other mammals result in
the synthesis exclusively of phaeomelanin, the yellow or red
pigment of hair. Humans with reduced-function variants of
MC1R have red hair. MC1R mRNA and protein are also
expressed in the central nervous system, in the periaqueductal gray
matter of the midbrain [18], an area known to be involved in pain
modulation [19]. A translational approach was undertaken by
Mogil and colleagues [17], providing evidence that MC1R plays a
female-specific role in k-opioid analgesia in Mc1r
e mutant mice
and correspondingly in humans with multiple MC1R variants.
Further work has shown alteration in the basal sensitivity of these
Mc1r
e mutant mice, with an increased tolerance to thermal (heat)
stimuli and in the tail clip and abdominal constriction tests [20]
with no sex specific difference noted. Such alteration in basal
sensitivity was replicated in humans, illustrated by a decreased
sensitivity to electrical stimulus [20]. Additionally, the analgesic
effects of clinically relevant m-opioid analgesics were assessed in
both mice and humans resulting in an increased analgesic
response, again with no significant effect of sex [20]. Further
characterisation of basal sensitivity in the human MC1R variant
female population has shown a substantially higher sensitivity to
cold pain, both perception and tolerance, and a slightly lower
tolerance of heat pain [21]. In addition, red haired females showed
decreased efficacy of subcutaneous lidocaine-induced analgesia,
however male MC1R variants were not tested in this study [21].
Two of the melanocortin (MC) receptors, MC1R and MC4R,
are unusual in that they have endogenous inverse agonists. All the
MC receptors are activated by MSH (a, b, and c forms; MC1R
has the highest affinity for a-MSH) and adrenocorticotrophin
(ACTH), which result in an increase in cAMP via coupling to G-
alpha-S, leading to production of black or brown eumelanin. The
endogenous inverse agonist, agouti signalling protein (ASP),
normally expressed in the dermal papilla of the hair follicles,
reduces MC1R signalling which leads to production of yellow/red
phaeomelanin. MC4R is expressed in the paraventricular nucleus
of the hypothalamus [22] and is involved in the regulation of
appetite and feeding behaviour. MC4R also has an additional
endogenous inverse agonist, agouti-related protein (AGRP). Gain
of function mutations of the gene encoding ASP in the mouse can
result in increased and widespread expression of the protein,
leading to a yellow coat through action on MC1R, but also to
obesity through ectopic inactivation of MC4R [23].
A number of additional physiological roles have been ascribed
to MC1R, in particular in mediating the established anti-
inflammatory activity of aMSH [24–26].
We have looked at the contribution of MC1R to naı ¨ve or basal
nociceptive responses to noxious and non-noxious stimuli, and
determined any sex differences in such responses, through the use
of mutant (Mc1r
e) mice. We also compared transgenic littermates
in which the Mc1r deficiency has been rescued to identify if any
alteration in behavioural responses could be rescued by the
introduction of the human MC1R gene. We examined the
contribution of Mc1r to pain states, of both inflammatory and
neuropathic origin, again determining any sex differences in
behavioural responses and whether introduction of human MC1R
rescued the behavioural alterations observed in Mc1r
e mice. In
addition we have used ASP-over-expressing mice, (whereby
MC1R and MC4R signalling is antagonised) to determine if
blocking MC1R results in similar behavioural responses to a non-
functioning MC1R. We finally looked at the contribution of
MC1R to trigeminal nociception through oral aversion testing to
capsaicin, which activates the noxious heat receptor, TRPV1 that
is expressed in mouse tongue [27]. We determined any sex
difference in MC1R’s contribution to oral aversion and the
outcome of rescuing MC1R function by introduction of human
MC1R.
Results
Mutant and Transgenic Mice
In order to study the role of Mc1r in nociception in more detail
we analysed the behavioural response to noxious and non-noxious
stimuli of mice with a range of genotypes. Recessive yellow mice,
Mc1r
e, are homozygous for the Mc1r
e allele and lack functional
Mc1r by virtue of a single base deletion in the Mc1r gene which
produces a frameshift at amino acid 183 and truncation of the
receptor in the second extracellular loop between transmembrane
domains 4 and 5. As a further comparison, and as a control for
genetic background, we used littermates of the recessive yellow
mice which have the mutant Mc1r
e allele but also contain the
human MC1R gene on a bacterial artifical chromosome [28].
These mice retain the normal regulation of human MC1R and
have a wild type, agouti, coat colour. The mouse MC1R, in
melanocytes at least, is able to signal independently of its cognate
ligand a-MSH [29,30], whereas the human MC1R requires
activation by aMSH in both humans and in transgenic mice
[28,31,32]. The endogenous inverse agonist of MC1R, ASP,
blocks both ligand-dependent and basal, ligand-independent,
signalling [28,33–36]. ASP is normally expressed only in the skin
where it modulates hair pigmentation. Mice with the dominant
mutation A
y-Jkn1, express ASP ubiquitously, and as a result have
yellow hair, but are also obese due the action of ASP on the related
receptor, MC4R. These mice were used to assess if antagonism of
MC1R results in similar behavioural responses to mice with a non-
functioning MC1R, by comparison to their non-mutant littermate
controls (control non-A
y-Jkn1).
Naı ¨ve female Mc1r
e mice have altered behavioural
responses to noxious hot temperature
The behavioural responses of naı ¨ve male and female adult mice
were assessed to noxious thermal and non-noxious mechanical
stimuli. When we measured paw withdrawal latency in response to
a noxious heat stimulus (Hargreaves’ thermal stimulator) we found
that female mice lacking Mc1r had an increased latency, indicating
a higher tolerance to noxious heat, compared to female littermate
mice with a normal mouse (data not shown) or human MC1R
(Figure 1A). Male mice showed no variation by genotype in
response to noxious heat stimuli. However we observed no
difference in response to mechanical stimuli between genotypes or
sex (Figure 1B). We also assessed the response of A
y-Jkn1 mice,
which have a dominant agouti mutation and express ASP
ubiquitously, and presumably signalling through MC1R is blocked
MC1R in Pain
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mutant mice as they have a pain response indistinguishable from
mice with a functional Mc1r.
MC1R contributes to pain of inflammatory origin
We assessed the behavioural responses of these mice to
inflammatory pain induced by injection of formalin into the
plantar surface of one hind paw. The number of paw flicks or
flinches was measured during both the first (5–15 min post-
injection) and second (20–45 min post-injection) phase of the
formalin response (Figure 2). Male mice of all genotypes did not
differ in their response (Figure 2A). Female Mc1r
e mice displayed a
reduced response during both the first and second phase when
compared to their littermate transgenic controls Tg-Mc1r
e
(Figure 2B). Interestingly, it appears that unlike noxious heat,
the difference in formalin-induced inflammatory pain response
can be modulated by inverse agonism by ASP. Female A
y-Jkn1 mice
show a reduced first and second phase formalin response
compared to control non- A
y-Jkn1 littermates suggesting that
blocking of signalling through one or more melanocortin receptors
reduces the formalin-induced inflammatory pain response.
Injection of Complete Freund’s Adjuvant (CFA) into the plantar
surface of one hind paw, as a model of persistent inflammation,
produces concomitant hyperalgesia (heightened pain response)
and allodynia (lowered pain threshold). In male mice this response
to inflammation can clearly be seen by increased sensitivity to
thermal and mechanical stimuli; within a few hours of injection,
the injured (ipsilateral) hind-paw’s withdrawal from noxious heat
has a reduced latency (hyperalgesia) (Figure 3A) and withdrawal
from mechanical stimulation occurs at a much lower pressure
(allodynia) (Figure 3B), when compared to the uninjured
(contralateral) hind-paw. All genotypes of male mice had the
same response.
Mutation of Mc1r delayed the development of thermal
hyperalgesia and mechanical allodynia in females. Whilst other
genotypes developed enhanced responses to noxious heat and
mechanical stimuli within a few hours, Mc1r
e females did not show
development of inflammation-induced sensitisation until 24 hours
post-injection. (Figure 3A, 3B).
MC1R does not contribute to neuropathic pain
In order to test the effect of MC1R on neuropathic pain we used
a chronic constriction injury (CCI) by loosely ligating the sciatic
nerve of mice [37]. Paw withdrawal latency in response to noxious
heat and the paw withdrawal threshold in response to mechanical
stimulus were measured on the injured hindlimb (ipsilateral) and
compared to the un-injured (contralateral) hindlimb as a control.
In all genotypes and both sexes there was a striking development of
thermal hyperalgesia and mechanical allodynia following surgery,
which resolved over the following 40 days. There were no
differences between genotypes in either sex, indicating that in
contrast to inflammatory pain, Mc1r does not appear to play a role
in neuropathic pain (Figure 4).
MC1R affects trigeminal nociception of chemical stimuli
The hindlimb withdrawal responses to noxious and non-noxious
stimuli, is mediated through the lumbar dorsal root ganglia and
spinal cord. Responses in the head and face region are mediated
through the trigeminal ganglia. The receptor responsible for
detection of noxious heat (TRPV1) responds to capsaicin (the
active compound in chilli). We asked if MC1R played a role in
response to this receptor through the trigeminal ganglia using an
oral aversion test. We offered mice lacking Mc1r and transgenic,
human MC1R-positive littermate controls, a choice of water or
highly dilute capsaicin, and assessed their consumption over a
period of 10 days. The capsaicin dose was increased after each
Figure 1. Behavioural responses to acute mechanical or noxious thermal stimuli in naı ¨ve animals. Adult male and female Mc1r
e and their
littermate controls Tg-Mc1r
e,o rA
y-Jkn1 and their littermate control non-A
y-Jkn1 mice were assessed for responses to acute noxious thermal or non-
noxious mechanical stimuli. The paw withdrawal latency (PWL; n=8–11 per genotype) [A], paw withdrawal threshold (PWT; n=8–11 per genotype)
[B] as measures of thermal hyperalgesia and mechanical allodynia respectively of both hind-paws (right and left hind-paw responses combined) in
naı ¨ve animals are shown as mean responses 6 SEM. Significant differences between Mc1r
e and A
y-Jkn1 and their respective controls were only seen in
female Mc1r
e mice in [A] paw withdrawal latency (***P,0.01).
doi:10.1371/journal.pone.0012498.g001
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capsaicin solution decreased, indicating that the mice find it
unpalatable. At higher concentrations (1.65–3.3 mM) all mice were
equally averse but we noted a threshold concentration of 0.83 mM
at which there was a genotype-specific difference (Figure 5A, 5B).
We tested a second cohort of naı ¨ve mice at this concentration and
replicated this difference in consumption. As might be predicted
from their higher tolerance of noxious heat, female Mc1r
e mice
consumed a much higher proportion of capsaicin than their
transgenic, control littermates Tg-Mc1r
e (Figure 5B, 5C). Male
mice of either genotype consumed an equal proportion of the
capsaicin solution (Figure 5A, 5C).
The results of all the nociception assays performed are
summarised in Table 1.
Discussion
Previous work has demonstrated a role for MC1R in basal pain
perception and in response to analgesia in both mice and humans.
Most studies have found that only females demonstrated an effect
of mutant MC1R. We have shown here that, in our assessments of
acute pain perception, female, but not male, Mc1r mutant mice
(Mc1r
e) have an altered response to noxious thermal stimuli,
displaying an increased tolerance of noxious heat stimuli. We have
extended the analysis to examine formalin-induced inflammatory
pain and the heightened pain perception to thermal and
mechanical stimuli as a result of CFA-induced inflammation.
The formalin model of inflammation is a well characterised test
[38], which has been shown to elicit a biphasic nociceptive
response, an acute/first phase (lasting for 5–10 minutes following
injection), and a tonic/second phase (lasting from 20–40 minutes
until the nocifensive response diminishes to baseline). The acute
phase of the formalin response is thought to be produced by direct
excitation of nociceptors at the site of injury, while the second
phase involves both ongoing peripheral activity and central
sensitisation in the spinal cord [39]. While licking/biting
behaviours are a more dependent measure of the formalin
response we have looked at the number of flinch/flick (lifting)
Figure 2. Effect of MC1R functionality on the Formalin Response. Data represents the number of paw flinch or flick responses per min 6 SEM
following the intraplantar injection of formalin in [A] male and [B] female adult Mc1r
e, Tg-Mc1r
e, A
y-Jkn1and control non-A
y-Jkn1 mice (n=5–9 per
genotype). There was no significant difference in the formalin response occurring over time (0–60 min post-injection) for male Mc1r
e or A
y-Jkn1 when
compared to their control groups Tg-Mc1r
e and control non-A
y-Jkn1 respectively. Significant differences for female Mc1r
e or A
y-Jkn1 when compared to
their respective control groups Tg-Mc1r
e and control non-A
y-Jkn1 are shown *P,0.05; **P,0.01 (Mc1r
e compared to Tg-Mc1r
e) and {P,0.05;
{{P,0.01; {{{P,0.001 (A
y-Jkn1 compared to control non-A
y-Jkn1).
doi:10.1371/journal.pone.0012498.g002
MC1R in Pain
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responses observed [40]. Here female Mc1r
e mutant mice have a
decreased nocifensive response during both phases of formalin-
induced inflammation that is also observed in female A
y-Jkn1,
indicating that antagonism of melanocortin receptors in addition
to a non-functional MC1R results in reducing the formalin
response. The role of MC4R in reducing the formalin response
cannot be ruled out in the A
y-Jkn1 mice; indeed the second phase of
the formalin response has been shown to be attenuated by
antagonists that preferentially act on MC4R [41]. In addition,
inflammation-induced hyperalgesia and allodynia following intra-
plantar injection of CFA is delayed by 24 hours, such that the
injured hindlimb of Mc1r
e females does not initially differ in
sensitivity to the un-injured hindlimb. However CFA-induced
hyperalgesia and mechanical allodynia is apparent at 24 and
48 hours, with the same degree of behavioural sensitisation
observed as with Tg-Mc1r
e, A
y-Jkn1 and control non-A
y-Jkn1.
Interestingly although there is no behavioural effect of mutant
MC1R on naı ¨ve mechanical sensitivity, the onset of mechanical
allodynia in this model of persistent inflammation is delayed. The
delay in thermal hyperalgesia is reflective of the basal sensitivity,
where an increased tolerance to noxious heat is found. It appears
that inflammation-induced hyperalgesia corresponds to basal
sensitivity of the Mc1r
e mice, perhaps indicating a potential role
Figure 3. Effect of MC1R functionality on CFA-induced thermal hyperalgesia and mechanical allodynia. Data represents the paw
withdrawal latency [A], paw withdrawal threshold [B] as measures of thermal hyperalgesia and mechanical allodynia prior to and post-injection of
CFA (n=4–5 per genotype), shown as mean responses 6 SEM. Differences in behaviours prior to injection were observed in female Mc1r
e mice only,
when compared to their control littermates, Tg-Mc1r
e in [A] paw withdrawal latency ({{P,0.01). CFA-induced increased ipsilateral sensitivity (IPSI;
injured hindlimb) compared to contralateral (CON; un-injured hindlimb) are shown (*P,0.05). Female Mc1r
e mice were found to have a significantly
higher ipsilateral thresholds when compared to their control littermates, Tg-Mc1r
e ipsilateral thresholds in [A] paw withdrawal latency and [B] paw
withdrawal threshold at 0.5–2 hours post-injection ("P,0.05).
doi:10.1371/journal.pone.0012498.g003
MC1R in Pain
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that may be continued post-injury.
Previous work has shown that antagonism of MC1R alone
results in behavioural responses similar to Mc1r
e mice [17].
However whether the absence of effect observed in the A
y-Jkn1 mice
is a result of dual antagonism of the MC1R and MC4R would
need to be further investigated (for example through use of MC4R
antagonists in the Mc1r
e mice). Furthermore, the possibility that
other melanocortin receptors might compensate when both
MC1R and MC4R are blocked cannot be ruled out. It is also
worth noting that the A
y-Jkn1 mice are obese as a result of inhibiting
the MC4R, and the role that this has to play in terms of
behavioural reflex assessment of the hindlimb needs further
clarification. It is interesting that in these mice the basal sensitivity
(assessed through use of quantitative sensory testing, which relies
on application of thermal or mechanical stimulus to the plantar
surface of the hindpaw), shows no change. The formalin response
results in spontaneous pain-related (ie nocifensive) behaviours and
is therefore independent of plantar stimulus application. When
such a spontaneous response is assessed the behavioural response
seen in the Mc1r
e mice is replicated in the A
y-Jkn1 mice, with no
alteration observed in the control non-A
y-Jkn1 littermates. MC1R
has been extensively reported to have a role in mediating anti-
inflammatory activity of aMSH [24–26], indeed aMSH has been
reported to reduce the formalin response [42]. The role of this
receptor in behavioural responses here appears to differ from these
findings, with inactivity of the MC1R not resulting in a normal or
pro-inflammatory response but rather a reduced inflammatory
nocifensive response.
Conversely we report a lack of effect of mutant MC1R on
chronic pain of neuropathic origin. MC4R, which is expressed
both peripherally in the dorsal root ganglia [43] and centrally in
the spinal cord and brain [44], has been reported as playing a role
in neuropathic pain through use of antagonists (that are more
selective for MC4R over MC3R) following peripheral nerve-
injury, resulting in reversal of injury-induced behavioural
sensitisation [45–47]. We find here that neither antagonism of
the MC1R nor a non-functional MC1R influences nerve-injury
Figure 4. Behavioural analysis of CCI-induced thermal hyperalgesia and mechanical allodynia. Data represent the paw withdrawal
latency [A], paw withdrawal threshold [B] as measures of thermal hyperalgesia and mechanical allodynia respectively in male and female Mc1r
e, Tg-
Mc1r
e, A
y-Jkn1 and control non-A
y-Jkn1 adult mice, prior to- and post-surgery shown as the area under the curve (AUC; which measures the total change
over the time course (baseline to post-surgery day 21) of CCI-induced thermal hyperalgesia and mechanical allodynia; n=5–6 per genotype). AUC’s
were calculated from raw data by the standard trapezoidal rule. No significant differences in either male or female mice were observed.
doi:10.1371/journal.pone.0012498.g004
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of development of nerve-injury induced sensitivity. Additionally no
alteration as a result of strain or sex was noted. The expression of
MC4R has been shown to increase in the spinal cord after
peripheral nerve-injury [47]. Following axotomy, no alteration in
MC1R mRNA expression is seen in dorsal root ganglia and
decreases in both MC2R and MC3R, but MC4R mRNA
increases following axotomy [48], perhaps suggesting a greater
role for MC4R than MC1R in nerve injury. However, we
observed no alteration or reduced development of nerve-injury
induced behavioural sensitisation in A
y-Jkn1 mice, where MC4R
function is also blocked by the inverse agonist ASP. Perhaps the
balance between agonist and endogenous inverse agonist activities
is crucial to determining how the melanocortin system interacts
with or regulates nociceptor function.
To further explore the potential involvement of MC1R with
TRP channels in addition to trigeminal nociception, we used a
two-bottle paired preference paradigm oral aversion test [49]. This
Figure 5. Concentration-dependent aversion to capsaicin consumption. Concentration related aversion to capsaicin in adult [A] male and
[B] female Mc1r
e and their control littermates Tg-Mc1r
e (n=6–7 per genotype). Data is expressed as an aversion index ranging from 21 to 1, which
measures the degree to which the solution was avoided during the 10 day exposure at each capsaicin concentration tested 6 SEM and was
calculated by subtracting capsaicin consumed from water consumed, differences in Mc1r
e consumption of capsaicin are shown (**P,0.01) compared
to control Tg-Mc1r
e group. [C] Shows the concentration threshold for capsaicin (at 0.83 mM) in the first trial of male and female mice, followed by a
repeat trial in naı ¨ve animals (not previously assessed for oral aversion) data is expressed as the volume capsaicin containing solution consumed as a
percentage of body weight 6 SEM during the 10 day exposure, differences in Mc1r
e consumption of capsaicin at 0.83 mM are shown ({{P,0.01)
compared to control Tg-Mc1r
e group.
doi:10.1371/journal.pone.0012498.g005
MC1R in Pain
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activate the TRP channel; TRPV1, which is selectively activated
by noxious heat (.43uC) or capsaicin [50]. We have shown an
increased tolerance to noxious heat in female Mc1r
e mice. Using
these mice and their control littermates Tg-Mc1r
e we investigated
whether aversion to capsaicin would also be altered by mutant
MC1R. We found increased tolerance to heat can be extended to
increased tolerance to capsaicin in female Mc1r
e mice only. We
repeated this assessment in an independent set of naı ¨ve male and
female Mc1r
e and Tg-Mc1r
e mice and found this increased
tolerance was repeated. This suggests the role for MC1R in
TRP activation or signalling extends to chemical activation as well
as thermal.
In summary we provide further evidence for the role for MC1R
not only in acute thermal sensitivity but also in pain of
inflammatory origin that is female specific. The existing data for
the role of MC1R in the human population appears to differ in
outcome for tolerance of thermal stimuli [20,21]. Our study
provides additional evidence that mutation of MC1R contributes
to an increased tolerance to thermal stimuli, similar to data
presented by Mogil and colleagues [20]. While an altered response
to cold and heat has been examined in humans [21], to test the
conservation of this reported behavioural response to humans, it
would be interesting to examine basal sensitivity to a range of
temperatures and capsaicin sensitisation in both male and female
MC1R human variants. We suggest an interaction between
MC1R and TRP channel activation or signaling may occur but
whether this may occur through direct or indirect activation needs
to be examined. We highlight further the importance of MC1R in
female pain modulation.
Materials and Methods
Animals, surgery and experimental groups
All experiments were carried out in accordance with the UK
Animals (Scientific Procedures) Act, 1986, and approved by the
University of Edinburgh Ethical Review Committee and per-
formed under UK Home Office project and personal licences.
Adult male and female mice of four genotypes were used in this
study, summarized in Table 2. Recessive yellow mice, Mc1r
e, lack a
functional MC1R. To control for genetic background, Tg-Mc1r
e,
are littermates of the Mc1r
e mice, which contain human MC1R
gene on a bacterial artificial chromosome [28], leading to rescue of
the non-functioning MC1R such that the yellow mutant
pigmentation becomes a normal agouti coat colour as previously
described [28]. Mice with a dominant mutation of agouti, A
y-Jkn1,
in which ASP (the endogenous inverse agonist of MC1R) is
ubiquitously expressed and results in a yellow coat colour were
used to assess antagonism of MC1R (these mice are also obese due
to ASP’s action on MC4R). Non-mutant littermates of A
y-Jkn1,
control non-A
y-Jkn1, have a black coat colour due to the nonagouti
allele, do not express ASP and were used as controls for A
y-Jkn1. All
animals were housed in groups (except in the oral aversion tests) at
a temperature of 21uC 61uC with a 12/12 hour light/dark cycle
and had ad libitum access to food and water.
Formalin was used to induce an experimental model of
inflammatory pain [38] Under aseptic conditions formalin (10 ml
of a 1.5% solution in saline; Sigma) was injected into the plantar
surface of one hind paw under halothane/O2 anesthesia.
Responses were characterised as the number of flinches/flicking
(lifting behaviour) over 1 min in the injected hindpaw and
recorded at 5 min intervals until 60 min post injection. Results
are expressed as the mean number of paw flinches or flicks per
minute 6 SEM. Sample sizes were 5–9 per genotype.
Complete Freund’s Adjuvant was used to induce an
experimental model of persistent inflammatory pain [51].
Complete Freund’s adjuvant (CFA 1 mg/ml; Sigma) was injected
(1 ml/gram body weight) under aseptic conditions into the plantar
surface of one hind paw under halothane/O2 anesthesia. Sample
sizes were 4–5 per genotype.
Peripheral Nerve Injury was induced under aseptic
conditions using a unilateral chronic constriction injury (CCI)
Table 1. Summary of Results.
MALE FEMALE
Mc1r
e compared
to Tg-Mc1r
e
A
y-Jkn1 compared
to control non-A
y-Jkn1
Mc1r
e compared
to Tg-Mc1r
e
A
y-Jkn1 compared
to control non-A
y-Jkn1
Acute test (naı ¨ve animals)
Noxious heat no difference no difference increased threshhold no difference
Mechanical no difference no difference no difference no difference
Formalin response (tonic inflammation)
Response no difference no difference decreased response decreased response
CFA (model of persistent inflammation)
Noxious heat no difference no difference delayed sensitivity no difference
Mechanical no difference no difference delayed sensitivity no difference
CCI (model of peripheral neuropathy)
Noxious heat no difference no difference no difference no difference
Mechanical no difference no difference no difference no difference
Capsaicin oral aversion
(activation of noxious heat receptor)
Aversion no difference not tested reduced aversion not tested
Results are summarized for adult male and female mice comparing; Mc1r
e, recessive yellow mice with their littermate controls Tg-Mc1r
e and A
y-Jkn1, agouti signalling
protein over-expressing mice with their littermate controls, control non-A
y-Jkn1. All mice were tested for behavioural responses to acute (noxious thermal or mechanical
stimuli) tests, formalin response, CFA and CCI-induced thermal hyperalgesia and mechanical allodynia, oral aversion was tested in Mc1r
e and Tg-Mc1r
e mice only.
doi:10.1371/journal.pone.0012498.t001
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sciatic nerve was exposed and loosely ligated with 3 chromic catgut
ligatures (5/0, Ethicon) placed about 1 mm apart under
halothane/O2 anesthesia. Sample sizes were 5–6 per genotype.
Behavioural Testing
Quantitative sensory reflex testing of mechanical allodynia and
thermal hyperalgesia was performed on naı ¨ve, CCI and CFA
injured animals (n=8–11 per genotype), prior to surgery or
injection to obtain baseline values and post-surgery/injection.
Mechanical allodynia was assessed as paw withdrawal threshold
(PWT), using calibrated von Frey filaments (Stoelting) applied to
the plantar surface of the hindpaw, to determine the indentation
pressure (mN/mm
2) required to elicit a response (defined as the
pressure required to elicit a paw withdrawal to at least 50% of
applications, i.e. 4 out of 8 applications). Thermal hyperalgesia
was measured using the Hargreaves’ thermal stimulator (Ugo
Basile) that applies a quantified noxious radiant heat to the plantar
surface of the hindpaw, to monitor the paw withdrawal latency
(PWL) in seconds [52]. Behavioural responses were recorded both
ipsilateral and contralateral to injury pre- and post-surgery/
injection, with responses obtained at each time point presented as
the mean 6 SEM.
Oral Aversion Test
To evaluate the contribution of MC1R to trigeminal nocicep-
tion, we used a paired preference paradigm aversive drinking test
in Mc1r
e and Tg-Mc1r
e male and female adult mice to assess oral
aversion to capsaicin. Capsaicin stock solutions were prepared as a
3.3 mM stock solution of capsaicin (Sigma) by dissolving in 30%
ethanol and serial dilutions of the stock produced working
concentrations of 0.33 mM, 0.83 mM, 1.65 mM and 3.3 mM. The
paired preference paradigm set up was used to assess capsaicin
induced oral aversion as described previously [49]. Briefly, each
trial involved two water bottles, one containing capsaicin at the
given concentration and one bottle containing water with ethanol
at appropriate concentrations (to match the concentration found
in the test solution, with the maximum concentration of ethanol
(0.16%) not equalling that of either the maximum capsaicin
solution to prevent the possibility of intoxication). All mice were
housed one per cage on a 12/12 hour light/dark cycle, with ad
libitum access to food and both bottles. To measure volumes
consumed bottles were weighed (during the same 2 hour time
point of 10am–12pm) on alternate days over a 10 day test. In
order to prevent a position preference, the position of the bottles
were switched at each weighing, so each solution was positioned
on the right or left position for an equal number of days. On
completion of the 10 day test all mice had free access to two new
water bottles (containing water) for a minimum of 4 days before
the next higher concentration of capsaicin solution was tested. A
control cage was set up as outlined without any animal, to control
for any spillage from both bottles on movement of cages and to
control for possible evaporation of solutions. Raw consumption
weights for each bottle were expressed as a percentage of total
volume consumed for each group at each concentration. An
aversion index was calculated as per Simons et al. [49], by
subtracting the percentage of capsaicin consumed from the
percentage of water consumed, resulting in an aversion index
range of 21t o+1. Using this aversion index, 21 indicates
capsaicin is wholly preferred to water, 0 indicates equal preference
and +1 indicates water is wholly preferred. Data is presented as the
aversion index as a function of capsaicin concentration. When
significance in oral aversion to a particular concentration of
capsaicin was found data is also presented as the raw consumption
weights as a percentage of body weight 6 SEM for each group at
that concentration. Sample sizes were 6–7 per genotype.
Analysis
Statistical analysis of data (presented as means 6 SEM) was
carried out as follows, with significance set at p,0.05. Paw
withdrawal latencies were analysed by one way repeated-measures
ANOVA with Bonferroni post-hoc test, paw withdrawal threshold
were analysed by Friedman repeated-measures ANOVA on ranks
with Bonferroni post-hoc test. Injury-induced ipsilateral differenc-
es (compared to contralateral values) were measured by student’s t-
test for paw withdrawal latencies and by Mann-Whitney rank sum
test for paw withdrawal thresholds. Formalin response (genotype6
response) and oral aversion (genotype 6 concentration) were
assessed by two way ANOVA with Bonferroni post-hoc test. Oral
aversion results presented at a single concentration were analysed
by one way ANOVA with Bonferroni post-hoc test at that
concentration. Areas under the curve (AUC) for CCI-induced
mechanical allodynia and thermal hyperalgesia were calculated
from raw data converted to AUC (to post-surgery day 21) using
the standard trapezoidal rule, differences were determined by one-
way ANOVA with Tukey’s post-hoc test.
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